Patient Guide: A Study to Assess Efficacy and Safety of Efgartigimod PH20 SC in Adults With Ocular Myasthenia Gravis

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 78 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT06558279
Status: 🟢 Enrolling Now
Condition: Myasthenia Gravis, Ocular
Phase: PHASE3

Where You Can Participate

This study is available at 78 locations across the country.

Top locations include:
  • • Scottsdale, Arizona
  • • Boca Raton, Florida
  • • Boca Raton, Florida
  • • And 75 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Study to Assess Efficacy and Safety of Efgartigimod PH20 SC in Adults With Ocular Myasthenia Gravis - Join Clinical Trial NCTNCT06558279

How to Join This Clinical Trial - NCTNCT06558279

Learn how to participate in this PHASE3 trial studying an investigational therapy for Myasthenia Gravis, Ocular. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Myasthenia Gravis, Ocular. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Myasthenia Gravis, Ocular
Treatment Being Tested
Investigational treatment
Study Phase
PHASE3 - Large-scale efficacy study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT06558279 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 78 locations. Find a study site near you:

Clinical Research Site

Scottsdale, Arizona 85251 - United States

Status: RECRUITING

Clinical Research Site

Boca Raton, Florida 33428-4221 - United States

Status: RECRUITING

Clinical Research Site

Boca Raton, Florida 33487-2768 - United States

Status: RECRUITING

Clinical Research Site

Maitland, Florida 32751 - United States

Status: RECRUITING

Clinical Research Site

Tampa, Florida 33620 - United States

Status: RECRUITING

Clinical Research Site

Chicago, Illinois 60611 - United States

Status: RECRUITING

Clinical Research Site

New Brunswick, New Jersey 08901 - United States

Status: RECRUITING

Clinical Research Site

Durham, North Carolina 27710 - United States

Status: RECRUITING

Clinical Research Site

Cleveland, Ohio 44195 - United States

Status: RECRUITING

Clinical Research Site

Columbus, Ohio 43221 - United States

Status: RECRUITING

And 68 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE3 clinical trial for Myasthenia Gravis, Ocular:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships